# Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction

> **NCT02316041** · NA · UNKNOWN · sponsor: **Tilganga Institute of Ophthalmology** · enrollment: 220 (estimated)

## Conditions studied

- Hyperopia

## Interventions

- **PROCEDURE:** Small incision lenticule extraction
- **DEVICE:** ReLEx® (SMILE)

## Key facts

- **NCT ID:** NCT02316041
- **Lead sponsor:** Tilganga Institute of Ophthalmology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2018-12
- **Final completion:** —
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2018-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02316041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02316041, "Clinical Trial of the Femtosecond Laser System VisuMax for Refractive Correction of Hyperopia by Means of Lenticule Extraction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02316041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*